Last update:
Oncology & Cancer news
Oncology & Cancer
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 patients with small cell lung cancer and brain metastases, finding they experienced positive outcomes ...
5 hours ago
0
0
Decades of data reveal no clear liver cancer link to oral contraceptive pills
The National Cancer Institute and University of Oxford report that oral contraceptive use is not associated with increased liver cancer risk, based on a population-based analysis of more than 1.5 million women and a review ...
Modified personalized cancer vaccine generates powerful immune response
Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called NeoVaxMI is safe, feasible, ...
Jul 10, 2025
0
1
Gene-editing platform could boost anti-cancer immune responses
Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies to treat cancer.
Jul 10, 2025
0
12
An FDA-approved drug halts Epstein-Barr virus-driven lymphoma by disrupting a key cancer pathway
Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can effectively combat Epstein-Barr virus (EBV)-driven lymphomas. The findings, published in the Journal ...
Jul 10, 2025
0
26
New research uncovers link between cancer pathway and blood-retina barrier function
A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously unrecognized roles in retina and brain blood vessels. The findings were recently published in Science ...
Jul 10, 2025
0
0
Most patients with advanced melanoma remain disease-free 4 years after pre-surgical immunotherapy, study finds
Four years after pre-surgery treatment with a novel combination of immune checkpoint inhibitors, nivolumab and relatlimab, 87% of patients with stage III melanoma remained alive, according to new results from a study led ...
Jul 10, 2025
0
0
A key protein helps liver cancer resist heat-based treatment
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver tumors return quickly after thermal ablation, a widely used minimally-invasive, image-guided technique ...
Jul 10, 2025
0
0
New survival benchmark for patients with advanced biliary tract cancer reached using combination therapy
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the first-line treatment ...
Jul 10, 2025
0
0
New AI model could help scientists pinpoint signs of cancer cells
The Chan Zuckerberg Initiative (CZI) reports its latest AI model aimed at helping researchers better understand how cells behave by focusing on the key networks that control cell behavior, making complex biological problems, ...
Jul 10, 2025
0
0
Researchers develop biosensor based on light and AI for early diagnosis of cancer
Dr. Ho Sang Jung and his research team from the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science (KIMS) have developed an optical biosensor capable of detecting trace amounts ...
Jul 10, 2025
0
0
Varying associations ID'd between hormone therapy, young-onset breast cancer
Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in the July issue of The Lancet Oncology.
Jul 10, 2025
0
0
New research offers reassurance about localized prostate cancer prognosis
New research in JNCCN—Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated according to NCCN Clinical Practice Guidelines ...
Jul 10, 2025
0
0
Vaccines work: Data show real-world evidence of stable protection against HPV-related cervical cancer
Among the more than 100 types of human papillomavirus (HPV), at least 14 are considered as "high-risk" types which can cause (cervical) cancer. After breast cancer, cervical cancer is the most common cancer in Europe among ...
Jul 10, 2025
0
0
Cooling and antioxidants could prevent hair loss during chemotherapy
Hair loss is one of the most feared and traumatic side effects of cancer chemotherapy treatment, both for patients themselves and their loved ones, as it can visibly represent the "face of cancer."
Jul 10, 2025
0
1
Breathing dirty air may raise the risk of a common brain tumor
People exposed to higher levels of air pollution may be more likely to develop meningioma, a typically noncancerous brain tumor, according to a large study published in Neurology. This common type of brain tumor forms in ...
Jul 9, 2025
0
81
Gut microbes may hold key to understanding how exercise boosts cancer immunotherapy response
A new study from the University of Pittsburgh shows for the first time how exercise improves cancer outcomes and enhances response to immunotherapy in mice by reshaping the gut microbiome.
Jul 9, 2025
0
19
Real-time trial shows AI could speed cancer care
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how doctors determine ...
Jul 9, 2025
0
35
Cellular signature explains why some prostate tumors resist standard treatments
A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.
Jul 9, 2025
0
13
Scientists reveal how Epstein-Barr virus protein EBNA-LP rewires DNA to drive cancer
Scientists at The Wistar Institute have discovered how a key protein from the Epstein-Barr virus (EBV), EBNA-LP, fundamentally rewires the three-dimensional structure of DNA in infected B cells to promote cancer development.
Jul 9, 2025
0
0
Aggressive breast cancer triggered by obesity-related blood signals, study shows
Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to its high incidence and significant mortality rates. In the U.S. alone, approximately 297,790 new ...
Jul 9, 2025
0
0
New method traces cancer cell evolution from a single tissue sample
Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the formation of a malignant tumor.
Jul 9, 2025
0
0
Novel T-cell subtypes in follicular lymphoma linked to patient prognosis
Researchers at University of Tsukuba have identified multiple T-cell subtypes with unique characteristics in follicular lymphoma, a prevalent type of blood cancer. These T cells regulate the proliferation and apoptosis of ...
Jul 9, 2025
0
0
Updated guidelines improve throat cancer staging
Cedars-Sinai investigators led an update of staging guidelines for HPV-positive throat cancer—now more common in the U.S. than cervical cancer, according to the American Cancer Society—that will make treatment of early-stage ...
Jul 9, 2025
0
0
